Atlas Trials

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

Clinical trial NCT04942405 · COMPLETED

Trial details

NCT number
NCT04942405
Sponsor
Health Institutes of Turkey
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19
Start date
2021-06-21
Primary completion
2023-03-08
Enrollment
1290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.